Ningbo Liu, Doctor
Tianjin Medical University Cancer Institute and Hospital
1
1
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Dingzhi Huang, Doctor
Tianjin Medical University Cancer Institute and Hospital
Shared therapeutic areas:
Worked with same sponsors:
Marc Fellous, MD
Sr. Vice President, Clinical Development and Medical Affairs
Shared therapeutic areas:
Joel W Neal, MD, PhD
Stanford University
Shared therapeutic areas:
Akin Atmaca, PD Dr. med.
Krankenhaus Nordwest, Frankfurt, Deutschland
Shared therapeutic areas:
Dong Wang, PH.D
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Shared therapeutic areas:
Joachim von Pawel, MD
Askelios Klinik München Gauting
Shared therapeutic areas:
Shun Lu, Professor
Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiaotong University, P. R. China
Shared therapeutic areas:
Giorgio Scagliotti, MD
University of Turin San Luigi Hospital
Shared therapeutic areas:
Yin Cheng, Professor
Jilin Provincial Tumor Hospital
Shared therapeutic areas:
Xuan Zhao, Ph.D.
JenKem Technology Co., Ltd.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer
All 1 trials loaded